• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Estimated Risk of Adverse Surgical Outcomes Among Patients With Recent COVID-19 Infection Using Target Trial Emulation Methods.

作者信息

O'Brien William J, Gupta Kalpana, Itani Kamal M F

机构信息

Center for Healthcare Organization and Implementation Research, Veterans Affairs Boston, Boston, Massachusetts.

Department of Medicine, Veterans Affairs Boston, Boston, Massachusetts.

出版信息

JAMA Netw Open. 2023 Mar 1;6(3):e234876. doi: 10.1001/jamanetworkopen.2023.4876.

DOI:10.1001/jamanetworkopen.2023.4876
PMID:36976565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10051067/
Abstract
摘要

相似文献

1
Estimated Risk of Adverse Surgical Outcomes Among Patients With Recent COVID-19 Infection Using Target Trial Emulation Methods.使用目标试验模拟方法评估近期感染新型冠状病毒肺炎患者手术不良结局的风险
JAMA Netw Open. 2023 Mar 1;6(3):e234876. doi: 10.1001/jamanetworkopen.2023.4876.
2
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.一项评估 SARS-CoV-2 疫苗（灭活，Vero 细胞）有效性和安全性的随机、双盲、安慰剂对照 III 期临床试验：一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.
3
Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.在医院环境中评估羟氯喹化学预防 SARS-CoV2 感染在医护人员中的疗效和安全性的对照、双盲、随机试验：一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):472. doi: 10.1186/s13063-020-04400-4.
4
COVID-19 Vaccination Effectiveness Against Infection or Death in a National U.S. Health Care System : A Target Trial Emulation Study.美国国家医疗体系中 COVID-19 疫苗对感染或死亡的有效性：一项目标试验模拟研究。
Ann Intern Med. 2022 Mar;175(3):352-361. doi: 10.7326/M21-3256. Epub 2021 Dec 21.
5
Severity and 1-month outcome of SARS-CoV-2 infection in patients with solid cancers: a Danish nationwide cohort study.实体瘤癌症患者感染 SARS-CoV-2 的严重程度和 1 个月预后：一项丹麦全国队列研究。
Acta Oncol. 2021 Jul;60(7):859-865. doi: 10.1080/0284186X.2021.1889659. Epub 2021 Mar 1.
6
Clinical and epidemiological aspects of SARS-CoV-2 infection among pregnant and postpartum women in Mozambique: a prospective cohort study.莫桑比克孕妇和产后妇女感染 SARS-CoV-2 的临床和流行病学特征：一项前瞻性队列研究。
Reprod Health. 2022 Jul 19;19(1):164. doi: 10.1186/s12978-022-01469-9.
7
Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study.伴有非重症 COVID-19 的肿瘤患者接受全身性抗癌治疗的安全性：一项队列研究。
BMC Cancer. 2021 May 20;21(1):578. doi: 10.1186/s12885-021-08349-8.
8
The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.SARS-CoV-2 依维莫司纳瓦拉-ISGlobal 试验（SAINT）评估依维莫司在症状出现后 48 小时内降低低危、非重症 COVID-19 患者 COVID-19 传播风险的潜力：一项随机对照试验方案的研究方案结构化总结。
Trials. 2020 Jun 8;21(1):498. doi: 10.1186/s13063-020-04421-z.
9
Surgical Outcomes in Cancer Patients Undergoing Elective Surgery After Recovering from Mild-to-Moderate SARS-CoV-2 Infection.轻症至中度 SARS-CoV-2 感染康复后择期手术的癌症患者的手术结局。
Ann Surg Oncol. 2021 Dec;28(13):8046-8053. doi: 10.1245/s10434-021-10291-9. Epub 2021 Jun 26.
10
Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol.在 COVID-19 疫情期间，比利时初级保健提供者中针对 SARS-CoV-2 的抗体的流行率和发生率：前瞻性队列研究方案。
BMJ Open. 2022 Jan 31;12(1):e054688. doi: 10.1136/bmjopen-2021-054688.

引用本文的文献

1
Pulmonary complications and mortality among COVID-19 patients undergoing a surgery: a multicentre cohort study.COVID-19 患者手术相关的肺部并发症和死亡率：一项多中心队列研究。
BMJ Open. 2024 Nov 21;14(11):e090158. doi: 10.1136/bmjopen-2024-090158.
2
Expanded analysis for patients with acute cholecystitis indicates outcomes vary based on COVID-19 status and treatment modality.对急性胆囊炎患者的扩展分析表明，结果因 COVID-19 状态和治疗方式而异。
J Gastrointest Surg. 2024 Jul;28(7):1113-1121. doi: 10.1016/j.gassur.2024.05.005. Epub 2024 May 6.
3
Does Recent COVID-19 Infection Impact Safety of Nasal Surgery?近期感染新冠病毒对鼻科手术安全性有何影响？
Facial Plast Surg Aesthet Med. 2024 Nov-Dec;26(6):766-768. doi: 10.1089/fpsam.2023.0352. Epub 2024 Mar 26.
4
Postoperative Outcomes Associated with the Timing of Surgery After SARS-CoV-2 Infection.新冠病毒感染后手术时机与术后结局的关系。
Ann Surg. 2024 Aug 1;280(2):241-247. doi: 10.1097/SLA.0000000000006227. Epub 2024 Feb 7.

本文引用的文献

1
To Wait or Not to Wait?: COVID-19 Vaccination Mitigates Adverse Surgical Outcomes.等待还是不等待？：新冠病毒疫苗接种可减轻手术不良结局
Ann Surg. 2022 Nov 1;276(5):e273-e274. doi: 10.1097/SLA.0000000000005675. Epub 2022 Aug 9.
2
Timing of a Major Operative Intervention After a Positive COVID-19 Test Affects Postoperative Mortality: Results From a Nationwide, Procedure-matched Analysis.阳性新冠病毒检测后择期大型手术干预时机影响术后死亡率：一项全国范围内、基于手术匹配的分析结果。
Ann Surg. 2022 Sep 1;276(3):554-561. doi: 10.1097/SLA.0000000000005552. Epub 2022 Jul 15.